NCT04487483

Brief Summary

Sufficient sleep is crucial for good health, yet a third of UK adults have impaired sleep quality. Therefore, there is urgent need for population-level sleep interventions. However, many sleep interventions (such as Cognitive Behavioural Therapy for Insomnia) are resource intensive and not widely available. Research demonstrates that smartphone interventions are an effective way to reach the wider population. However, many commercially available smartphone sleep applications focus on one technique, and hence do not tailor to the diverse needs of individuals. A new sleep app offers six different techniques, allowing individuals to shape their own journey to improved sleep quality. The investigators aim to test the sleep app's efficacy and gather user experience data to allow app optimisation. The study is a two-arm pilot randomised control trial (RCT). After recruitment and screening, baseline measurements will be taken: subjective sleep quality data will be collected using the Insomnia Severity Index (ISI) and the Consensus Sleep Diary from all participants and objective accelerometry data via an Oura Ring (worn on finger for a week) on a subsample of participants. Participants will then be randomised to the intervention or control. Intervention participants will be given free use of the sleep app for 3 months. Controls will be informed that they will not receive access to the intervention and will be asked to abstain from using any other digital sleep-based intervention during the 3 months. All participants will be given the ISI after each month and will be given the Consensus Sleep Diary to fill out for one week again after 2 months. The planned Oura ring follow-up after 2 months for participants who wore the Oura ring at baseline has been cancelled due to COVID-19. User engagement will be assessed using the Digital Behaviour Change Intervention Engagement Scale. Telephone interviews will also be conducted with 20-30 participants to explore experience of using the app, how the comparison group felt about being allocated to the control group and how the COVID-19 pandemic may have affected their sleep and other measures of the study. Change in self-reported sleep will be the primary outcome and qualitative user data secondary. Appropriate tests (such as an ANOVA or linear regression controlling for baseline sleep and testing for effect of group when using continuous data) and thematic analysis of qualitative interview data will be conducted.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2020

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

July 7, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 27, 2020

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2020

Completed
Last Updated

August 11, 2020

Status Verified

August 1, 2020

Enrollment Period

4 months

First QC Date

July 7, 2020

Last Update Submit

August 7, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in self-reported sleep quality

    Measured using the Insomnia Severity Index. The scores from the Insomnia Severity Index range from 0 to 28, where higher scores indicate worse sleep quality.

    Baseline/1 month/2 months/3 months

Secondary Outcomes (3)

  • Change in self-reported sleep

    Baseline/2 months

  • Engagement with the sleep app

    Once a week for 3 months

  • Telephone interview qualitative user data

    Up to 6 months

Study Arms (2)

Sleep App

EXPERIMENTAL

Participants in this condition will receive full free access to the "Pro" version of the sleep app and asked to use the app every day for three months.

Behavioral: Sleep App

Control

NO INTERVENTION

Participants in this condition will be asked to continue their life as normal and abstain from downloading or using any sleep aid and/or sleep tracker app for three months.

Interventions

Sleep AppBEHAVIORAL

A sleep app offering 6 evidence based techniques to improve sleep (such as Cognitive Behavioural Therapy for Insomnia, Progressive Muscle Relaxation and Mindfulness Meditation), allowing for a personally tailored journey of sleep aids within the app.

Sleep App

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 or above
  • Own a smartphone

You may not qualify if:

  • Having a clinically diagnosed sleep disorder for which they are currently being treated
  • Frequent use (once a week or more) of any sleep medication
  • Enrolment on another sleep trial
  • Being unwilling to cease usage of other sleep apps for the duration of the study
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College London

London, WC1E 7HB, United Kingdom

Location

Related Publications (1)

  • Armitage BT, Potts HWW, Irwin MR, Fisher A. Exploring the Impact of a Sleep App on Sleep Quality in a General Population Sample: Pilot Randomized Controlled Trial. JMIR Form Res. 2024 Aug 13;8:e39554. doi: 10.2196/39554.

Study Officials

  • Abi Fisher

    University College, London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The study is a two-arm pilot RCT where participants are randomly assigned to either the intervention or control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Physical Activity and Health

Study Record Dates

First Submitted

July 7, 2020

First Posted

July 27, 2020

Study Start

February 13, 2020

Primary Completion

June 17, 2020

Study Completion

August 15, 2020

Last Updated

August 11, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Pilot study and the investigators plan to disseminate findings in a peer reviewed publication and a masters thesis.

Locations